Franklin Resources’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,267,927
| Closed | -$77.2M | – | 2982 |
|
|
2023
Q4 | $77.2M | Sell |
3,267,927
-39,988
| -1% | -$712K | 0.04% | 392 |
|
|
2023
Q3 | $49.3M | Buy |
3,307,915
+35,907
| +1% | +$476K | 0.03% | 499 |
|
|
2023
Q2 | $35.8M | Buy |
3,272,008
+47,146
| +1% | +$439K | 0.02% | 623 |
|
|
2023
Q1 | $28.1M | Buy |
3,224,862
+3,201,765
| +13,862% | +$25.6M | 0.01% | 685 |
|
|
2022
Q4 | $145K | Hold |
23,097
| – | – | ﹤0.01% | 2067 |
|
|
2022
Q3 | $81K | Sell |
23,097
-1,367
| -6% | -$4.91K | ﹤0.01% | 2137 |
|
|
2022
Q2 | $72K | Sell |
24,464
-988
| -4% | -$2.36K | ﹤0.01% | 2198 |
|
|
2022
Q1 | $79K | Sell |
25,452
-5,381
| -17% | -$16.9K | ﹤0.01% | 2328 |
|
|
2021
Q4 | $104K | Sell |
30,833
-83,385
| -73% | -$317K | ﹤0.01% | 2337 |
|
|
2021
Q3 | $417K | Buy |
114,218
+92,215
| +419% | +$363K | ﹤0.01% | 1962 |
|
|
2021
Q2 | $96K | Hold |
22,003
| – | – | ﹤0.01% | 1917 |
|
|
2021
Q1 | $100K | Sell |
22,003
-207
| -0.9% | -$1.11K | ﹤0.01% | 1872 |
|
|
2020
Q4 | $127K | Sell |
22,210
-277
| -1% | -$2.1K | ﹤0.01% | 1779 |
|
|
2020
Q3 | $163K | Buy |
+22,487
| New | +$120K | ﹤0.01% | 1687 |
|
|
2020
Q2 | – | Sell |
-1,151,356
| Closed | -$1.7M | – | 1750 |
|
|
2020
Q1 | $1.7M | Hold |
1,151,356
| – | – | ﹤0.01% | 1123 |
|
|
2019
Q4 | $2.26M | Hold |
1,151,356
| – | – | ﹤0.01% | 1152 |
|
|
2019
Q3 | $5.89M | Hold |
1,151,356
| – | – | ﹤0.01% | 972 |
|
|
2019
Q2 | $8.24M | Buy |
1,151,356
+28,100
| +3% | +$318K | ﹤0.01% | 937 |
|
|
2019
Q1 | $14.9M | Sell |
1,123,256
-610,844
| -35% | -$6.5M | 0.01% | 799 |
|
|
2018
Q4 | $13.6M | Hold |
1,734,100
| – | – | 0.01% | 809 |
|
|
2018
Q3 | $19.2M | Sell |
1,734,100
-64,600
| -4% | -$802K | 0.01% | 796 |
|
|
2018
Q2 | $24.1M | Hold |
1,798,700
| – | – | 0.01% | 723 |
|
|
2018
Q1 | $23.4M | Buy |
1,798,700
+350,000
| +24% | +$4.35M | 0.01% | 739 |
|
|
2017
Q4 | $13.3M | Sell |
1,448,700
-51,300
| -3% | -$438K | 0.01% | 880 |
|
|
2017
Q3 | $12.1M | Buy |
+1,500,000
| New | +$10.1M | 0.01% | 906 |
|
Other funds holding CBAY
Franklin Resources's CBAY Position: Q1 2024 in Review
Franklin Resources sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 3,267,927 shares — an estimated $77.2M sold.
Franklin Resources first reported a position in CBAY in Q3 2017 and held it in 25 quarters. The position peaked at $77.2M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.
- Franklin Resources reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
- Franklin Resources sold 3,267,927 Cymabay Therapeutics shares in Q1 2024, an estimated $77.2M.
- Franklin Resources first reported a position in Cymabay Therapeutics in Q3 2017 and held it in 25 quarters.
- Franklin Resources's Cymabay Therapeutics position peaked at $77.2M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.
Based on Franklin Resources's 13F filing for Q1 2024, filed 13 May 2024.